TRIM27 promotes IL-6-induced proliferation and inflammation factor production by activating STAT3 signaling in HaCaT cells

被引:57
|
作者
Miao, Xiao [1 ,2 ]
Xiang, Yanwei [1 ,3 ]
Mao, Weiwei [1 ]
Chen, Yiran [1 ]
Li, Qi [1 ]
Fan, Bin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, 110 Gan He Rd, Shanghai 200437, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2020年 / 318卷 / 02期
基金
中国国家自然科学基金;
关键词
PIAS3; psoriasis; STAT3; TRIM27; ubiquitination; IFN-GAMMA; PSORIASIS; IL-6; EXPRESSION; CARCINOMA;
D O I
10.1152/ajpcell.00314.2019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The IL-6/STAT3 signaling pathway is required for the development of psoriatic lesions, and tripartite motif-containing 27 (TRIM27) is a protein inhibitor of activated STAT3 (PIAS3)-interacting protein that could modulate IL-6-induced STAT3 activation. However, whether TRIM27 is associated with the IL-6/STAT3 signaling pathway in psoriasis remains enigmatic. TRIM27 expression and gene set enrichment analysis in patients with psoriasis were determined using bioinformatics. Human keratinocyte HaCaT cells treated with recombinant protein IL-6 (rh-IL-6) were transduced with lentivirus silencing TRIM27 and/or PIAS3 or, otherwise, transduced with lentivirus expressing TRIM27 and/or lentivirus silencing STAT3, or MG132, a proteasome-specific protease inhibitor. Cell proliferation and inflammation factor production were measured using Cell Counting Kit-8 and ELISA, respectively. TRIM27, proliferation marker protein Ki-67 (Ki67), phospho-STAT3 (pSTAT3), STAT3, and PIAS3 expressions were determined using real-time quantitative PCR, immunofluorescence staining, or Western blot analysis. Coimmunoprecipitation combined with ubiquitination analysis was performed to explore the interaction between TRIM27 and PIAS3. In the present study, TRIM27 expression was increased in psoriatic lesions, associated with the IL-6 signaling pathway, and induced by rh-IL-6 in a time-dependent manner. The increased cell proliferation, inflammation factor production, and expression of Ki67 and of p-STAT3 relative to STAT3 induced by rh-IL-6 and TRIM27 overexpression were significantly inhibited by TRIM27 silencing and STAT3 silencing, respectively. More importantly, TRIM27 interacted with PIAS3, and its overexpression promoted PIAS3 ubiquitination in HaCaT cells. PIAS3 silencing also significantly promoted TRIM27dependent and 1L6-induced STAT3 activation, cell proliferation, and inflammation factor production. In conclusion, our results highlight that TRIM27 expression is significantly increased by IL-6 and suggest a TRIM27/STAT3-dependent mechanism for regulation of inflammation and proliferation-associated development of psoriasis.
引用
收藏
页码:C272 / C281
页数:10
相关论文
共 50 条
  • [31] SerpinB1 promotes the proliferation of porcine pancreatic stem cells through the STAT3 signaling pathway
    Xu, Shuanshuan
    Qin, Dezhe
    Yang, Hong
    He, Chen
    Liu, Wenqing
    Tian, Na
    Wei, Yudong
    He, Xin
    Hua, Jinlian
    Peng, Sha
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2020, 198
  • [32] Kruppel-like Factor 2 Inhibits Proliferation in Renal Angiomyolipoma via IL-6/JAK/STAT3 Signaling Pathway
    Liu, Chung-Yi
    Chang, Tzu-Hsuan
    Hsieh, Chin-Hsuan
    Chang, Ying-Hsu
    Pang, Jacob See-Tong
    Chuang, Cheng-Keng
    ANTICANCER RESEARCH, 2022, 42 (10) : 4753 - 4762
  • [33] Ntrk1 promotes mesangial cell proliferation and inflammation in rat glomerulonephritis model by activating the STAT3 and p38/ERK MAPK signaling pathways
    Dong, Xiongjun
    Tang, Yingchun
    BMC NEPHROLOGY, 2022, 23 (01)
  • [34] Long noncoding RNA DANCR promotes nasopharyngeal carcinoma progression by interacting with STAT3, enhancing IL-6/JAK1/STAT3 signaling
    Zhang, Xixia
    Yang, Jing
    Bian, Zhigang
    Shi, Dong
    Cao, Zhiwei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 113
  • [35] Role of IL-6 and STAT3 signaling in dihydropyridine-induced gingival overgrowth fibroblasts
    Lu, Sao-Lun
    Huang, Chiung-Fang
    Li, Chuan-Li
    Lu, Hsein-Kun
    Chen, Li-Sheng
    ORAL DISEASES, 2021, 27 (07) : 1796 - 1805
  • [36] IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway
    Zhang, Zhu
    Zhou, Bin
    Zhang, Kui
    Song, Yaping
    Zhang, Lin
    Xi, Mingrong
    MOLECULAR IMMUNOLOGY, 2016, 78 : 155 - 163
  • [37] Baicalin Inhibits Cell Proliferation and Inflammatory Cytokines Induced by Tumor Necrosis Factor α (TNF-α) in Human Immortalized Keratinocytes (HaCaT) Human Keratinocytes by Inhibiting the STAT3/Nuclear Factor kappa B (NF-κB) Signaling Pathway
    Wu, Xianwei
    Deng, Xiue
    Wang, Jiandi
    Li, Qin
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [38] STAT3 Promotes Schistosome-Induced Liver Injury by Inflammation, Oxidative Stress, Proliferation, and Apoptosis Signal Pathway
    Zhao, Jie
    Liu, Xin
    Chen, Yao
    Zhang, Lin-Shuang
    Zhang, Ya-Rong
    Ji, Deng-Ren
    Liu, Shi-Meng
    Jia, Mo-Zhi
    Zhu, Yong-Hong
    Qi, Yong-Fen
    Lu, Feng-Min
    Yu, Yan-Rong
    INFECTION AND IMMUNITY, 2021, 89 (03)
  • [39] HCS Campaign to Identify Selective Inhibitors of IL-6-Induced STAT3 Pathway Activation in Head and Neck Cancer Cell Lines
    Johnston, Paul A.
    Sen, Malabika
    Hua, Yun
    Camarco, Daniel P.
    Shun, Tong Ying
    Lazo, John S.
    Wilson, Gabriela Mustata
    Resnick, Lynn O.
    LaPorte, Matthew G.
    Wipf, Peter
    Huryn, Donna M.
    Grandis, Jennifer R.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2015, 13 (07) : 356 - 376
  • [40] Aspirin Inhibits Carcinogenesis of Intestinal Mucosal Cells in UC Mice Through Inhibiting IL-6/JAK/STAT3 Signaling Pathway and Modulating Apoptosis and Proliferation
    Chen, Yingying
    Sun, Liying
    Li, Dongyue
    Yin, Xunhai
    Shang, Guoyin
    Diao, Tiantian
    Shi, Lijun
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (09) : 731 - 742